Skip to content

pain management by siravedh chikitsa In Vatarakta

To study the effect of siravedh chikitsa in instant pain management in vatarakta with special reference to gout - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070686
Enrollment
40
Registered
2024-07-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E799- Disorder of purine and pyrimidinemetabolism, unspecified Health Condition 2: E799- Disorder of purine and pyrimidinemetabolism, unspecified

Interventions

None listed

Sponsors

DR MAYURI DINESH THAKRE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnose with Vatarakta. Patients with Uric Acid Level more than 7.0 mg/dl in male and more than 6.0 mg/dl in female

Exclusion criteria

Exclusion criteria: Patients known bleeding disorders. Patients with Anemia. patients with uncontrolled diabetes and Hypertension.

Design outcomes

Primary

MeasureTime frame
1. Pain B.OBJECTIVE CRITERIA 1. SwellingTimepoint: 8th Day

Secondary

MeasureTime frame
Effect of Siravedh Chikitsa on Pain & Swelling in VataraktaTimepoint: After 1 week

Countries

India

Contacts

Public ContactDr Mayuri Dinesh Thakre

DR GD POL FOUNDATION YMT AYURVEDIC MEDICAL COLLEGE AND HOSPITAL

spbadole20@gmail.com9167750838

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026